BTG Competitors and Similar CompaniesClear all

BTG's competitors and similar companies include Zogenix, NIOX, Durect and Paion.
BTG
BTG
BTG is an international specialist healthcare company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
NIOX
NIOX
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Founding Date
Founding Date
1948
Founding Date
2006
Founding Date
2006
Founding Date
N/A
Founding Date
2000
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Yokne'am Illit, IL
see more
Locations
Emeryville, US HQ
Maidenhead, GB
Locations
Morrisville, US HQ
Bad Homburg Vor Der Höhe, DE
Uppsala, SE
Morrisville, US
Locations
Cupertino, US HQ
Locations
Aachen, DE HQ
Odense, DK
Hoofddorp, NL
Richmond, GB
Employees
Employees
619
Employees
731% decrease
Employees
92
Employees
902% increase
Employees
3218% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
340.9 m
Valuation ($)
45.3 m
Valuation ($)
49.7 m

Financial

Revenue (est.)
Revenue (est.)
£731.3m (FY, 2019)
Revenue (est.)
$81.7m (FY, 2021)
Revenue (est.)
£17k (FY, 2016)
Revenue (est.)
$8.5m (FY, 2023)
Revenue (est.)
€33.2m (FY, 2022)
Cost of goods
Cost of goods
£221m (FY, 2019)
Cost of goods
$4.8m (FY, 2021)
Cost of goods
N/A
Cost of goods
$1.7m (FY, 2023)
Cost of goods
€382k (FY, 2022)
Gross profit
Gross profit
£510.3m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$6.8m (FY, 2023)
Gross profit
€33.4m (FY, 2022)
Net income
Net income
£88.3m (FY, 2019)
Net income
($227.4m) (FY, 2021)
Net income
£17k (FY, 2016)
Net income
($27.6m) (FY, 2023)
Net income
(€579k) (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 122.8m
Total funding raised
$ 20m
Total funding raised
$ 15.2m
For sources of this data, please see the company profile

View Company Profiles

Zogenix
HQ
Emeryville, US

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
NIOX
HQ
Morrisville, US
Employees
92

NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies

View company
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.

View company
Paion
HQ
Aachen, DE
Employees
32↓ 18% decrease

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.

View company